Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board

HB 1440 prevents Medicaid plans and certain health insurers from requiring extra approval steps (like prior authorization) or limiting coverage for prescription drugs reviewed by Maryland's Prescription Drug Affordability Board (PDAB). It specifically applies when the PDAB hasn't determined a drug causes cost concerns, has made a policy recommendation, or set a payment limit for the drug. This directly affects patients using these medications by reducing barriers to accessing covered drugs. The bill updates Maryland's health insurance and Medicaid laws to enforce these restrictions on managed care organizations and insurers.